Aparito - a wholly owned subsidiary of Eli Lilly and Company Email Format
Hospitals and Health CareWales, United Kingdom11-50 Employees
Aparito is a healthcare technology company and a wholly owned subsidiary of Eli Lilly and Company, operating in the hospitals and health care sector. It is based in Wrexham, Wales, United Kingdom, with a workforce of 11 to 50 employees, and maintains the website aparito.com. The company develops digital solutions to digitise clinical trials and accelerate drug development for patients with life-limiting diseases, delivering patient-centric trials through its Atom5 eCOA platform that combines video assessments, wearable devices, and electronic patient-reported outcomes to collect real-world data. Aparito has received industry recognition and engaged in collaborations, including being named a finalist in a 2023 Innovation in STEM category, partnering with ISOQOL in 2022 to deliver the SBQ-LC PRO across mobile and web platforms, and receiving the EURORDIS Company Award for Health Technology in 2022. The firm has also announced collaborations with Raazi and the University of Birmingham to develop digital health platforms for clinical trials and patient care.